AUGUSTUS RUSH

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. ncbi [Vagus nerve stimulation. A potential therapy for chronic/recurrent depression?]
    A J Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Fortschr Neurol Psychiatr 70:297-302. 2002
  2. ncbi Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9086, USA
    Control Clin Trials 25:119-42. 2004
  3. ncbi Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Biol Psychiatry 58:347-54. 2005
  4. ncbi Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Biol Psychiatry 58:355-63. 2005
  5. pmc Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis
    Bradley N Gaynes
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7160, USA
    Ann Fam Med 5:126-34. 2007
  6. ncbi Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, 75390 9086, USA
    J Clin Psychiatry 64:357-69. 2003
  7. pmc Developing the evidence for evidence-based practice
    A John Rush
    Department of Clinical Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, Tex 75390 9066, USA
    CMAJ 178:1313-5. 2008
  8. ncbi Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 9086, USA
    Am J Psychiatry 163:1905-17. 2006
  9. ncbi Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting
    A John Rush
    University of Texas Southwestern Medical Center at Dallas, Department of Psychiatry, Dallas, Texas 75390 9086, USA
    Depress Anxiety 21:26-32. 2005
  10. ncbi Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Neuropsychopharmacology 30:405-16. 2005

Detail Information

Publications65

  1. ncbi [Vagus nerve stimulation. A potential therapy for chronic/recurrent depression?]
    A J Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Fortschr Neurol Psychiatr 70:297-302. 2002
    ..Ongoing studies will have to better establish its acute and longer-term efficacy, and specific indications in the treatment of depression...
  2. ncbi Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9086, USA
    Control Clin Trials 25:119-42. 2004
    ..Participants with an adequate symptomatic response may enter the 12-month naturalistic follow-up phase with brief monthly and more complete quarterly assessments...
  3. ncbi Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Biol Psychiatry 58:347-54. 2005
    ..Vagus nerve stimulation (VNS) alters both concentrations of neurotransmitters or their metabolites and functional activity of central nervous system regions dysregulated in mood disorders. An open trial has suggested efficacy...
  4. ncbi Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    Biol Psychiatry 58:355-63. 2005
    ..The need for effective, long-term treatment for recurrent or chronic, treatment-resistant depression is well established...
  5. pmc Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis
    Bradley N Gaynes
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7160, USA
    Ann Fam Med 5:126-34. 2007
    ....
  6. ncbi Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, 75390 9086, USA
    J Clin Psychiatry 64:357-69. 2003
    ....
  7. pmc Developing the evidence for evidence-based practice
    A John Rush
    Department of Clinical Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, Tex 75390 9066, USA
    CMAJ 178:1313-5. 2008
  8. ncbi Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 9086, USA
    Am J Psychiatry 163:1905-17. 2006
    ..This report describes the participants and compares the acute and longer-term treatment outcomes associated with each of four successive steps in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial...
  9. ncbi Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting
    A John Rush
    University of Texas Southwestern Medical Center at Dallas, Department of Psychiatry, Dallas, Texas 75390 9086, USA
    Depress Anxiety 21:26-32. 2005
    ..Overall, 9% of patients discontinued due to adverse events. Escitalopram treatment was well tolerated and associated with robust response rates in a broadly representative population of depressed outpatients...
  10. ncbi Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Neuropsychopharmacology 30:405-16. 2005
    ..Global patient ratings such as the PGI-I, as opposed to specific item-based ratings, provide less valid findings...
  11. ncbi Report by the ACNP Task Force on response and remission in major depressive disorder
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Neuropsychopharmacology 31:1841-53. 2006
    ..Research to evaluate these recommendations empirically is needed...
  12. ncbi Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    N Engl J Med 354:1231-42. 2006
    ..After unsuccessful treatment for depression with a selective serotonin-reuptake inhibitor (SSRI), it is not known whether switching to one antidepressant is more effective than switching to another...
  13. pmc An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report
    A John Rush
    Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9086, USA
    Biol Psychiatry 59:493-501. 2006
    ..This report compares the performance of these three versions of the QIDS and the 17-item Hamilton Rating Scale for Depression (HRSD17)...
  14. ncbi Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features
    A John Rush
    Department of Psychiatry, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9086, USA
    J Affect Disord 87:43-55. 2005
    ..This study evaluated the clinical and sociodemographic features associated with various degrees of concurrent comorbidity in adult outpatients with nonpsychotic major depressive disorder (MDD)...
  15. ncbi Does pretreatment insomnia or anxiety predict acute response to bupropion SR?
    A John Rush
    Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    Ann Clin Psychiatry 17:1-9. 2005
    ..This retrospective analysis was conducted to determine whether pretreatment levels of insomnia or anxiety were associated with likelihood of or time to antidepressant response with bupropion sustained release (SR)...
  16. ncbi Limitations in efficacy of antidepressant monotherapy
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9066, USA
    J Clin Psychiatry 68:8-10. 2007
    ..Rates of remission for each consecutive monotherapy were increasingly lower, suggesting that a series of monotherapy options may not be the best treatment strategy for patients who are nonresponsive to an initial monotherapy...
  17. ncbi Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390, USA
    Arch Gen Psychiatry 65:870-80. 2008
    ..Little is known about selecting among second-step medications for major depressive disorder after intolerance or lack of remission with an initial selective serotonin reuptake inhibitor...
  18. ncbi The varied clinical presentations of major depressive disorder
    A John Rush
    Department of Clinical Science and Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9086, USA
    J Clin Psychiatry 68:4-10. 2007
    ..This article provides a brief review of the status of several of the most common subtypes in terms of their clinical features, biological correlates, course of illness, and treatment implications...
  19. ncbi Toward an understanding of bipolar disorder and its origin
    A John Rush
    Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas 75390, USA
    J Clin Psychiatry 64:4-8; discussion 28. 2003
    ..To facilitate early diagnosis and effective management, clinicians should be aware of the risk factors, possible causes, and comorbidities of bipolar disease...
  20. ncbi Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D
    William R Yates
    Department of Psychiatry, University of Oklahoma College of Medicine, Tulsa, OK 74135, USA
    Gen Hosp Psychiatry 26:421-9. 2004
    ..A significant percentage of patients with major depressive disorder (MDD) suffer from concurrent general medical conditions (GMCs)...
  21. ncbi Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh Medical Center, 3811 OHara St, Pittsburgh, PA 15213 2593, and Massachusetts General Hospital, USA
    Am J Psychiatry 164:739-52. 2007
    ..Cognitive therapy was compared with medication augmentation and switch strategies...
  22. ncbi Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes
    Ziad Nahas
    Brain Stimulation Laboratory, Department of Psychiatry, Medical University of South Carolina, Charleston, SC 29403, USA
    J Clin Psychiatry 66:1097-104. 2005
    ..We examined the effects of adjunctive VNS over 24 months in this cohort...
  23. ncbi A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial
    Bradley N Gaynes
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7160, USA
    Gen Hosp Psychiatry 27:87-96. 2005
    ..The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study (http://www.star-d.org) provides a unique opportunity to provide this comparison for patients with a major depressive disorder (MDD) requiring treatment...
  24. ncbi Acceptability of second-step treatments to depressed outpatients: a STAR*D report
    Stephen R Wisniewski
    Department of Psychiatry, Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, and Clinical Psychopharmacology Unit, Massachusetts General Hospital, Boston, USA
    Am J Psychiatry 164:753-60. 2007
    ..This study sought to identify factors that affect patients' willingness to accept different second-step treatment approaches...
  25. doi Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial
    Edward S Friedman
    Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    Depress Anxiety 26:612-21. 2009
    ..But nonresponse can include depression that worsened over the course of treatment, an outcome that has received scant attention...
  26. doi Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study
    Sidney Zisook
    Department of Psychiatry, University of California, San Diego, San Diego VA Medical Center, San Diego, California, USA
    J Affect Disord 117:63-73. 2009
    ..The purpose of this study was to determine whether, and in whom, treatment of MDD is associated with increased or emergent SI...
  27. ncbi Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination
    John Zajecka
    Department of Psychiatry, Rush Presbyterian St Luke s Medical Center, 1725 W Harrison Street, Suite 955, Chicago, IL 60612, USA
    J Clin Psychiatry 63:709-16. 2002
    ..This study compares the effects of antidepressant medication, psychotherapy, and combined treatment on sexual interest/satisfaction and function in patients with chronic major depression...
  28. ncbi Insured and non-insured depressed outpatients: how do they compare?
    Ira M Lesser
    Department of Psychiatry, Harbor UCLA Medical Center, The Los Angeles Biomedical Research Institute, Los Angeles, CA, USA
    Ann Clin Psychiatry 19:73-82. 2007
    ....
  29. ncbi Effect of age at onset on the course of major depressive disorder
    Sidney Zisook
    Department of Psychiatry, University of California, San Diego, CA 92093, USA
    Am J Psychiatry 164:1539-46. 2007
    ..This report assesses whether age at onset defines a specific subgroup of major depressive disorder in 4,041 participants who entered the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study...
  30. ncbi Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial
    Vicki A Nejtek
    Department of Psychiatry, University of North Texas Health Science Center at Fort Worth, TX 76107, USA
    J Clin Psychiatry 69:1257-66. 2008
    ....
  31. ncbi The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update
    Alexander L Miller
    Department of Psychiatry, The University of Texas Health Science Center at San Antonio, MC 7792, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    J Clin Psychiatry 65:500-8. 2004
    ..This article reports the recommendations developed in 2002 and 2003 by a group of experts, clinicians, and administrators...
  32. ncbi One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies
    A John Rush
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Biol Psychiatry 56:46-53. 2004
    ..The symptomatic outcomes of a cohort of public mental health sector depressed outpatients treated for 1 year are described to provide a benchmark for future long-term trials. Baseline moderators of outcome were evaluated...
  33. ncbi Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression
    Alan J Gelenberg
    Department of Psychiatry, Health Sciences Center, University of Arizona, PO Box 245002, Tucson, AZ 85724 5002, USA
    Biol Psychiatry 54:806-17. 2003
    ..This randomized, placebo-controlled study of the efficacy and safety of nefazodone in preventing recurrence was conducted for patients with chronic MDD...
  34. ncbi Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination
    Philip T Ninan
    Department of Psychiatry, Emory University School of Medicine, Atlanta, GA 30329, USA
    J Clin Psychiatry 63:434-41. 2002
    ....
  35. ncbi Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder
    Lewis L Judd
    Department of Psychiatry, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093 0603, USA
    Am J Psychiatry 161:1864-71. 2004
    ..Minor depressive disorder is both common and associated with significant psychosocial impairment. This study examined antidepressant treatment efficacy in a large group of patients with minor depressive disorder...
  36. ncbi What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression
    Bradley N Gaynes
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA
    Psychiatr Serv 60:1439-45. 2009
    ..STAR*D demonstrated that inclusion of more real-world patients in clinical trials is both feasible and informative. Policy implications of the findings, as well as the study's limitations, are discussed...
  37. ncbi Factors that differentiate early vs. later onset of major depression disorder
    Sidney Zisook
    Department of Psychiatry, University of California, San Diego, San Diego VA Medical Center, 9500 Gilman Dr, 0603R, La Jolla, CA 92093, USA
    Psychiatry Res 129:127-40. 2004
    ..Thus, pre-adulthood onset MDD is a particularly severe and chronic condition...
  38. ncbi Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study
    Maurizio Fava
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
    Psychiatr Clin North Am 26:457-94, x. 2003
    ..This article provides the overall rationale for STAR*D and details the rationale for key design, measurement, and analytic features of the study...
  39. doi Measuring use and cost of care for patients with mood disorders: the utilization and cost inventory
    T Michael Kashner
    Department of Clinical Sciences and Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    Med Care 47:184-90. 2009
    ..This article describes and tests the Utilization and Cost Inventory (UAC-I), a structured patient interview designed to measure costs of care when access to provider records is limited...
  40. ncbi Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, PA 15213 2593, USA
    J Clin Psychiatry 63:493-500. 2002
    ..As nefazodone-mediated blockade of serotonin-2 receptors may directly relieve insomnia associated with depression, we examined the more specific effects of CBASP and nefazodone, singly and in combination, on sleep disturbances...
  41. ncbi Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report
    Rchard C Shelton
    Department of Psychiatry, Vanderbilt University, Nashville, TN 37212, USA
    CNS Spectr 14:487-98. 2009
    ..Concomitant psychotropic medication (CPM) treatment is common in persons with major depression (MDD). However, relationships with patient characteristics and response to treatment are unclear...
  42. ncbi Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders
    Ellen Frank
    Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania 15213, USA
    Biol Psychiatry 52:631-54. 2002
    ..A rationale for the importance of each of these priorities is provided...
  43. ncbi A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression
    Mark S George
    Department of Psychiatry, Medical University of South Carolina, 67 President Street 502 N, Charleston, SC 29425, USA
    Biol Psychiatry 58:364-73. 2005
    ..To better understand these effects on long-term outcome, we compared 12-month VNS+TAU outcomes with those of a comparable TRD group...
  44. pmc Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study
    Sheila M Marcus
    Department of Psychiatry, University of Michigan Medical School, Ann Arbor, MI 48105, USA
    Compr Psychiatry 49:238-46. 2008
    ..This article examines sex differences in terms of illness attributes in a cohort of 2541 outpatients from across the United States who enrolled in the Sequenced Treatment Alternatives to Relieve Depression study...
  45. ncbi The Texas medication algorithm project: clinical results for schizophrenia
    Alexander L Miller
    Department of Psychiatry, MS 7792, University of Texas Health Science Center at San Antionio, 7703 Floyd Curl Drive, San Antonio, TX 78229 3900, USA
    Schizophr Bull 30:627-47. 2004
    ..In secondary comparisons of ALGO with the second TAU group, the greater improvement in cognitive functioning was again noted, but the initial symptom difference was not significant...
  46. ncbi The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs. quetiapine
    Paul A Nakonezny
    Department of Clinical Sciences, Division of Biostatistics, The University of Texas Southwestern Medical Center, Dallas, TX 75235 8828, USA
    J Sex Marital Ther 33:203-16. 2007
    ..20). In this 6-week randomized double-blind trial, higher serum prolactin level was related to greater impairment of sexual functioning in male outpatients who were treated with risperidone, but not with quetiapine...
  47. pmc Symptom features of postpartum depression: are they distinct?
    Ira H Bernstein
    Department of Psychology, University of Texas at Arlington, Arlington, TX 75390 9086, USA
    Depress Anxiety 25:20-6. 2008
    ..These symptomatic differences between postpartum and other depressives suggest the need to include agitation/restlessness and impaired concentration/decision-making among screening questions for postpartum depression...
  48. ncbi Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium
    Russell E Scheffer
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 8589, USA
    Am J Psychiatry 162:58-64. 2005
    ....
  49. doi Depression outcomes of Spanish- and english-speaking Hispanic outpatients in STAR*D
    Ira Lesser
    Department of Psychiatry, Harbor UCLA Medical Center, Torrance, CA 90509, USA
    Psychiatr Serv 59:1273-84. 2008
    ....
  50. doi Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients
    Roy H Perlis
    Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
    Neuropsychopharmacology 34:1819-28. 2009
    ..These hypothesis-generating analyses suggest the potential for glutamatergic treatment targets for sexual dysfunction during major depressive episodes...
  51. pmc Remission of maternal depression: relations to family functioning and youth internalizing and externalizing symptoms
    Cynthia Ewell Foster
    Department of Psychiatry, University of Michigan, Ann Arbor, MI 48105, USA
    J Clin Child Adolesc Psychol 37:714-24. 2008
    ..9% of the variance...
  52. ncbi Health-related quality of life in depression: a STAR*D report
    Ella J Daly
    Department of Psychiatry, University of Texas Southwestern Medical School at Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 9119, USA
    Ann Clin Psychiatry 22:43-55. 2010
    ..This report examined the psychological, physical, and social domains in a large sample of outpatients who entered the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial...
  53. pmc Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from STAR*D
    Bradley N Gaynes
    Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC, USA
    J Gen Intern Med 23:551-60. 2008
    ..Whether the acute outcomes of major depressive disorder (MDD) treated in primary (PC) or specialty care (SC) settings are different is unknown...
  54. ncbi Diurnal mood variation in outpatients with major depressive disorder: implications for DSM-V from an analysis of the Sequenced Treatment Alternatives to Relieve Depression Study data
    David W Morris
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390 9119, USA
    J Clin Psychiatry 68:1339-47. 2007
    ....
  55. ncbi Clinician ratings vs. global ratings of symptom severity: a comparison of symptom measures in the bipolar disorder module, phase II, Texas Medication Algorithm Project
    E Sherwood Brown
    Department of Psychiatry, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, 75390 8849, Dallas, TX, USA
    Psychiatry Res 117:167-75. 2003
    ..Global assessments by patients or physicians only moderately or poorly reflected BPRS(24) scores. Itemized symptom measures to gauge severity of illness or change over time are preferred over patient or physician global judgments...
  56. ncbi Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness
    Paul E Keck
    Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
    Compr Psychiatry 44:263-9. 2003
    ..The lack of observable prognostic impact may have been, in part, due to the relatively high morbidity and poor functional outcome of a substantial portion of the total cohort...
  57. ncbi Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination
    James H Kocsis
    Department of Psychiatry, Weill Cornell Medical College, New York, NY 10021, USA
    Psychopharmacol Bull 37:73-87. 2003
    ..COMB was associated with less symptom re-emergence during the continuation phase than either monotherapy, particularly for partial remitters...
  58. ncbi Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder
    Ellen B Dennehy
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Psychiatry Res 127:137-45. 2004
    ..The BDSS demonstrated superior sensitivity to symptom change, and an excellent level of agreement for classification of patients as either responders or non-responders with the BPRS24...
  59. doi STAR*D: revising conventional wisdom
    A John Rush
    Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA
    CNS Drugs 23:627-47. 2009
    ..Although switch and augmentation strategies could not be directly compared due to the equipoise stratified randomized design, the higher remission rates at step 2 with medication augmentation are intriguing and merit further study...
  60. ncbi A quality improvement process for implementing the Texas algorithm for schizophrenia in Ohio
    Naakesh A Dewan
    Department of Psychiatry, University of Cincinnati, Cincinati, Ohio 45219, USA
    Psychiatr Serv 54:1646-9. 2003
    ..The results of the study may guide other states in their implementation of algorithms...
  61. ncbi A descriptive analysis of minor depression
    Mark Hyman Rapaport
    Department of Psychiatry, University of California, San Diego, School of Medicine, La Jolla, 92037, USA
    Am J Psychiatry 159:637-43. 2002
    ..The authors provide a detailed clinical description of minor depression: its symptoms, level of disability, stability, and relationship to patient and family history of major depressive disorder...
  62. ncbi Remissions in maternal depression and child psychopathology: a STAR*D-child report
    Myrna M Weissman
    Department of Psychiatry, Columbia University and the New York State Psychiatric Institute, New York 10032, USA
    JAMA 295:1389-98. 2006
    ..Children of depressed parents have high rates of anxiety, disruptive, and depressive disorders that begin early, often continue into adulthood, and are impairing...
  63. pmc A psychometric evaluation of the CDRS and MADRS in assessing depressive symptoms in children
    Shailesh Jain
    Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA
    J Am Acad Child Adolesc Psychiatry 46:1204-12. 2007
    ..This study compared the psychometric properties of the Children's Depression Rating Scale-Revised (CDRS-R) and the Montgomery-Asberg Depression Rating Scale (MADRS) in children with major depressive disorder...
  64. ncbi Naturalistic study of the early psychiatric use of citalopram in the United States
    A John Rush
    The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390 9086, USA
    Depress Anxiety 16:121-7. 2002
    ..8%, whereas those without such a history had a discontinuation rate of 13.3%. Citalopram administered at an average dose of 23.6 mg/day was associated with favorable outcomes and was generally well tolerated...

Research Grants3

  1. Development of an Inventory of Depressive Symptomatology
    AUGUSTUS RUSH; Fiscal Year: 2003
    ..g., anxiety, irritability) (IDS-C and SR) that are in the public domain for use with patients across the age spans seen in practice and in research. ..
  2. Development of an Inventory of Depressive Symptomatology
    AUGUSTUS RUSH; Fiscal Year: 2004
    ..g., anxiety, irritability) (IDS-C and SR) that are in the public domain for use with patients across the age spans seen in practice and in research. ..
  3. Development of an Inventory of Depressive Symptomatology
    AUGUSTUS RUSH; Fiscal Year: 2005
    ..g., anxiety, irritability) (IDS-C and SR) that are in the public domain for use with patients across the age spans seen in practice and in research. ..